Part of Takeda Pharmaceutical Co., Ltd., Shire International Licensing BV is a company headquartered in Amsterdam, the Netherlands. The firm operates as a biotechnology company.

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with significant unmet medical needs. It aims to open the way for a broad range of disease-modifying therapies by modifying the intracellular and extracellular concentrations of these various electrolytes and ions in Chronic Kidney Disease and Gitelman’s Syndrome and by addressing the underlying mitochondrial pathology and inflammation associated with Acute Kidney Disease. Unicycive Therapeutics was founded in 2016 and is headquartered in Los Altos, California.

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Versa Power Systems Ltd., a subsidiary of FuelCell Energy, Inc., is a company headquartered in Canada that develops solid oxide fuel cell power generation systems.

Shire LLC provides pharmaceutical services. The company was founded in 2004 and is headquartered in Florence , KY.

Designs and manufactures batteries

AnorMED, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic drugs for the treatment of hematology, human immunodeficiency virus (HIV), and oncology. Its lead drug product candidate include MOZOBIL, which is under phase III clinical trial is used for cancer patients undergoing stem cell transplantation; and AMD070, which is under phase Ib/IIa trial is used as a HIV entry inhibitor.

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins; hormone drugs, and other metabolic drugs. The company was founded in June 1951 and is headquartered in Osaka, Japan.

Johnson Matthey is an international speciality chemicals company, founded almost 200 years ago in London. Technology leadership forms the basis of our strategy to deliver superior long term growth

Nanjing Cavendish Bioengineering Technology Co., Ltd., established on 2006-11-15, Business scope includes pharmaceutical products,Chemical Products,Technical development of biological products,technical consulting,technology transfer;Biochemicals(Does not contain drugs),Chemical product sales;Self-operated and agent import and export business of various commodities and technologies(Except where the state restricts enterprises to operate or prohibits the import and export of commodities and technologies);(Branches licensed to operate under the)Processing of pharmaceutical and chemical intermediate products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Drug Wholesale;pharmaceutical production;Drug import and export;Drug internet information service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Leshan Wonaixi Electronic Materials Co., Ltd. is located in Qianwei County, Leshan City, Sichuan Province, adjacent to the Lingxiu Emei and the mysterious Buddha, and at the intersection of Neiyi Expressway and National Highway 213. The transportation is very convenient. The company covers an area of 15000 square meters, with 5000 square meters of production plants and nearly 100 employees. Main production: rare earth oxides (lanthanum oxide, cerium oxide, praseodymium oxide, neodymium oxide, europium oxide); Rare earth nitrates (ammonium ceric nitrate, ceric nitrate, lanthanum nitrate, praseodymium nitrate, neodymium nitrate, europium nitrate); Rare earth chlorides (lanthanum chloride, cerium chloride, anhydrous cerium chloride, praseodymium chloride, neodymium chloride, neodymium chloride monohydrate, anhydrous neodymium chloride); Rare earth acetate (lanthanum acetate, cerium acetate, praseodymium acetate, neodymium acetate, europium acetate); Rare earth carbonate (lanthanum carbonate, cerium carbonate, praseodymium carbonate, neodymium carbonate); Rare earth hydroxide (lanthanum hydroxide, cerium hydroxide, neodymium hydroxide); Rare earth sulfate (ammonium ceric sulfate, ceric sulfate); Rare earth fluoride (lanthanum fluoride, neodymium fluoride, praseodymium neodymium fluoride, lithium fluoride); Zirconium series (zirconium nitrate, zirconium sulfate, zirconium acetate) and other fine chemical products, with an annual output value of 150 million yuan. It is recognized by Wonaixi that the development direction and product structure of world chemical industry are undergoing fundamental changes, fine chemical industry is developing towards high performance, functionality and low pollution, and environmental protection is receiving more and more attention. The company cooperates with relevant research institutes and patent holders to ensure that new products keep pace with the times. Adhere to upgrading and transforming traditional industries with high and new technologies, optimize the product structure, improve the technical content and added value of products, cultivate the core competitiveness of enterprises, pay attention to the construction of the management system and corporate culture, enhance the sense of social responsibility, and form a strict management system with its own characteristics, which is in line with the operation specifications and meets the market demand. The company relies on science and technology for development, and constantly provides users with high-quality products. With stable product quality, timely delivery time and perfect after-sales service, it has been praised by users. Vonaixi adheres to the corporate culture connotation of "enterprising, pragmatic, rigorous and cooperative", and constantly develops and innovates. With the business philosophy of technology as the core, quality as the life, and customer as the God, Wonaixi will become your reliable partner.

Baotou Ande Kiln Technology Co., Ltd., established on 2013-02-26, Business scope includes licensed business items:General cargo(The operating permit).General operating items:Processing and sales of thermal insulation refractory materials;Industrial kiln design and construction and sales of supporting products;Steel structure engineering construction;industrial cleaner,water treatment agent,Chemical Products(except dangerous goods),Rare earth products,Metallurgical charge,Non-ferrous metals,steel,Minerals,Office Supplies,Metal alloy products,building materials,Equipment,Sales of electromechanical equipment;Industrial kiln technology consulting service;Abnormal condition of blast furnace,Iron spout technology consulting service.

Tianjin Baotou Steel Rare Earth Research Institute Co., Ltd., established on 2012-07-05, Business scope includes rare earth,Research and development of metallurgical technology,technology transfer,consult,Serve,Riddle;Metallurgical Engineering Design;Rare earth products,metallurgical products,Chemical Products(Excluding dangerous chemicals and precursor drugs),Sales of Rare Earth Functional Materials.(If the above business scope involves industry licensing, the license certificate,Operate within the validity period,If the country has special franchise regulations, it shall be handled in accordance with the regulations.)

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Beijing Zhonghui Pharmaceutical Co., Ltd., a subsidiary of Cenway Technologies, Ltd., is a Chinese company located in Beijing that manufactures pharmaceutical products.

National Applied Research Laboratories is a Taiwanese private company located in Taipei with domestic subsidiaries. The firm operates research centers for science and technology.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.